Thursday, May 30, 2019 1:22:09 PM
Medical Research Collaborative / St. Pete, FL
A little googling on my part comes up with the location on 4th Street in St. Petersburg. Pretty much a non-descript office building of 3 stories with an insurance agency and an ice cream shop in the same building.
One firm listed at address is A PATH TO WELLNESS ….a holistic healing center. I'm not saying the same people as are writing the report, but I am inclined to think so...."where's there's smoke, there is fire".
Some links to both the firm and the address of the building....BLEND-PHARMA
https://www.healthprofs.com/us/naturopaths/a-path-to-wellness-saint-petersburg-fl/522199
http://www.naturalhealthbydrjackson.com/nutrametrix
https://www.blend-pharma.com/about-blend/
There is also an acupuncturist in the building, but not sure if associated with A Path to Wellness or Blend-Pharma.
I think I would rather have a half-gallon of Rocky Road ice cream from the ice-cream shop!!!
Enjoy your reading assignment for the day.
Cheers!
Flubber
A little googling on my part comes up with the location on 4th Street in St. Petersburg. Pretty much a non-descript office building of 3 stories with an insurance agency and an ice cream shop in the same building.
One firm listed at address is A PATH TO WELLNESS ….a holistic healing center. I'm not saying the same people as are writing the report, but I am inclined to think so...."where's there's smoke, there is fire".
Some links to both the firm and the address of the building....BLEND-PHARMA
https://www.healthprofs.com/us/naturopaths/a-path-to-wellness-saint-petersburg-fl/522199
http://www.naturalhealthbydrjackson.com/nutrametrix
https://www.blend-pharma.com/about-blend/
There is also an acupuncturist in the building, but not sure if associated with A Path to Wellness or Blend-Pharma.
I think I would rather have a half-gallon of Rocky Road ice cream from the ice-cream shop!!!
Enjoy your reading assignment for the day.
Cheers!
Flubber
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
